Telemedicine visits for neurology, including MS care, are generally satisfying and convenient for patients.
The study looked at patients who had online visits with neurologists during the COVID-19 pandemic. Most patients were happy with their telemedicine appointments; over 74% rated their experience as 8 out of 10 or higher. Many patients found it easier to attend appointments online instead of traveling, especially since 75% had missed a visit before due to transportation issues. However, some patients felt uncomfortable sharing personal information during video calls. Providers also liked telemedicine, with 75% believing it is a useful tool, but they noted it can be hard to do physical exams online.
MS patients and their caregivers should pay attention to these findings because telemedicine can make getting care easier and more convenient. Imagine being able to talk to your doctor from your own home without worrying about how to get there; that’s what telemedicine offers. It can especially help those who struggle with traveling or have other commitments. This means less stress and more time for you to focus on managing your MS symptoms. Healthcare providers can also benefit because they can reach more patients and make care more accessible.
The study had a small number of patients who responded to the survey, which may not represent everyone's experience. Also, while many patients had access to technology, some still found it hard to share personal information during online visits. This is important to consider because it means not everyone may feel comfortable with telemedicine, and improvements are needed to help those patients.
12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JMIR formative research often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.